This is consistent, the team said, with the prevailing hypothesis suggesting that [semaglutides] therapeutic effects arise from overlapping neurobiological mechanisms that modulate both metabolic regulation and reward-related pathways shared between obesity and alcohol use disorder. The team concluded: Findings from this trial provide support for broadening the indication for semaglutide to [include] AUD in patients with a BMI of 30 or greater, which could benefit millions. About 890 million adults globally have a BMI over 30, and in the U.S., 8 million adults are estimated to have obesity and high alcohol consumption
Full article here: To view or add a comment, sign in Around the world, millions of people who live with #obesity are at the point in their weight loss journey where, after successfully accessing and using prescription weight loss medications such as Wegovy or Mounjaro and having reached their initial weight loss goal, ask: what's next
Therefore, SCD is often referred as a monogenic disease with polygenetic manifestations (Driss et al., 2009)
Frequently Asked Questions (FAQs) Does Mounjaro wear off at the end of the week
I havent been able to find any reliable information linking this to autoimmune conditions
Several studies recommend splitting supplemental L-carnitine intake into two or three doses, says Rickelle Tallent, RDN, LD, owner of Tallent Nutrition & Wellness in Las Vegas, Nevada
